Ekso Bionics Holdings 第四季度 每股收益 $(0.14) 不及预期 $(0.07),销售额 $5.09M 超过预期 $5.05M

财报速递
04 Mar
Ekso Bionics Holdings(NASDAQ:EKSO)报告季度每股亏损 $(0.14),较分析师预期的 $(0.07)低100%。相较去年同期的每股亏损 $(0.22),这一数字增长了36.36%。公司报告季度销售额为 $5.09M,超过分析师预期的 $5.05M,增长了0.74%。与去年同期的 $4.85M相比,销售额增长了5.01%。

以上内容来自Benzinga Earnings专栏,原文如下:

Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.07) by 100 percent. This is a 36.36 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $5.09 million which beat the analyst consensus estimate of $5.05 million by 0.74 percent. This is a 5.01 percent increase over sales of $4.85 million the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10